⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL154813 | 0.88 | — | — | |
| SCHEMBL155496 | 0.83 | — | — | |
| SCHEMBL157034 | 0.83 | — | — | |
| SCHEMBL2288424 | 0.81 | — | — | |
| SCHEMBL155699 | 0.77 | — | — | |
| SCHEMBL151703 | 0.76 | — | — | |
| SCHEMBL25418462 | 0.69 | — | — | |
| SCHEMBL155348 | 0.69 | — | — | |
| SCHEMBL6260329 | 0.65 | — | — | |
| SCHEMBL6260334 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11661410-B2 | Tricyclic compounds as histone methyltransferase inhibitors | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2023-05-30 | — | — | US | disclosed |
| US-11584734-B2 | Tricyclic compounds as histone methyltransferase inhibitors | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2023-02-21 | — | — | US | disclosed |
| US-20230002351-A1 | TRICYCLIC COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS | GLOBAL BLOOD THERAPEUTICS, INC. | 2023-01-05 | — | — | US | disclosed |
| US-20200361896-A1 | TRICYCLIC COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS | GLOBAL BLOOD THERAPEUTICS, INC. | 2020-11-19 | — | — | US | disclosed |
| EP-3668863-A1 | TRICYCLIC COMPOUNDS AS HISTONE METHYL-TRANSFERASE INHIBITORS | Global Blood Therapeutics, Inc. (US) | 2020-06-24 | — | — | EP | disclosed |
| WO-2019036377-A1 | TRICYCLIC COMPOUNDS AS HISTONE METHYL-TRANSFERASE INHIBITORS | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2019-02-21 | — | — | WO | disclosed |
| WO-2019036384-A1 | TRICYCLIC COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2019-02-21 | — | — | WO | disclosed |
| US-9944623-B2 | Sterically hindered amine stabilizer | BASF SE (DE) | 2018-04-17 | — | — | US | disclosed |
| EP-2475655-B1 | STERICALLY HINDERED AMINE STABILIZER | BASF SE (DE) | 2017-10-11 | — | — | EP | disclosed |
| US-20160347736-A1 | STERICALLY HINDERED AMINE STABILIZER | BASF SE (DE) | 2016-12-01 | — | — | US | disclosed |
| US-9464070-B2 | Sterically hindered amine stabilizer | BASF SE (DE) | 2016-10-11 | — | — | US | disclosed |
| US-8895647-B2 | Sterically hindered amine stabilizer | BASF SE (DE) | 2014-11-25 | — | — | US | disclosed |
| US-20140336313-A1 | STERICALLY HINDERED AMINE STABILIZER | BASF SE (DE) | 2014-11-13 | — | — | US | disclosed |
| US-20120232197-A1 | STERICALLY HINDERED AMINE STABILIZER | BASF SE (DE) | 2012-09-13 | — | — | US | disclosed |
| EP-2475655-A1 | STERICALLY HINDERED AMINE STABILIZER | BASF SE (DE) | 2012-07-18 | — | — | EP | disclosed |
| WO-2011029744-A1 | STERICALLY HINDERED AMINE STABILIZER | BASF SE (DE) | 2011-03-17 | — | — | WO | disclosed |